Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-02-14 6:04 pm Purchase | 2024-12-31 | 13G | RxSight, Inc. RXST | BANK OF AMERICA CORP BAC | 2,181,788 5.400% | 2,181,788![]() (New Position) | Filing History |
2025-02-13 1:20 pm Sale | 2024-12-31 | 13G | RxSight, Inc. RXST | LORD ABBETT & CO. LLC | 1,715 0.000% | -1,975,285![]() (-99.91%) | Filing History |
2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | RxSight, Inc. RXST | RA Capital Management, L.P. | 3,916,825 9.900% | 512,540![]() (+15.06%) | Filing History |
2024-11-12 4:50 pm Unchanged | 2024-09-30 | 13G | RxSight, Inc. RXST | VANGUARD GROUP INC | 2,287,084 5.760% | 0 (Unchanged) | Filing History |
2024-11-12 09:40 am Sale | 2024-09-30 | 13G | RxSight, Inc. RXST | Artisan Partners Limited Partnership | 1,170,231 2.900% | -1,225,441![]() (-51.15%) | Filing History |
2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | RxSight, Inc. RXST | BlackRock Inc. BLK | 2,787,308 7.000% | 0 (Unchanged) | Filing History |
2024-11-04 1:52 pm Purchase | 2024-09-30 | 13G | RxSight, Inc. RXST | VANGUARD GROUP INC | 2,287,084 5.760% | 2,287,084![]() (New Position) | Filing History |
2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | RxSight, Inc. RXST | BlackRock Inc. BLK | 2,787,308 7.000% | 710,838![]() (+34.23%) | Filing History |
2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | RxSight, Inc. RXST | RA Capital Management, L.P. | 3,404,285 9.500% | 351,489![]() (+11.51%) | Filing History |
2024-02-14 07:54 am Purchase | 2023-12-31 | 13G | RxSight, Inc. RXST | LORD ABBETT & CO. LLC | 1,977,000 5.510% | 1,977,000![]() (New Position) | Filing History |
2024-02-12 06:19 am Purchase | 2023-12-31 | 13G | RxSight, Inc. RXST | Artisan Partners Limited Partnership | 2,395,672 6.700% | 2,395,672![]() (New Position) | Filing History |
2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | RxSight, Inc. RXST | BlackRock Inc. BLK | 2,076,470 5.800% | 2,076,470![]() (New Position) | Filing History |
2023-08-18 4:18 pm Sale | 2023-08-09 | 13D | RxSight, Inc. RXST | Longitude Capital Partners II LLC | 1,774,559 5.000% | -764,478![]() (-30.11%) | Filing History |
2023-06-05 4:52 pm Purchase | 2023-05-26 | 13D | RxSight, Inc. RXST | Longitude Capital Partners II LLC | 2,539,037 7.500% | 32,065![]() (+1.28%) | Filing History |
2023-02-14 4:55 pm Sale | 2022-12-31 | 13G | RxSight, Inc. RXST | ORBIMED ADVISORS LLC | 923,733 3.300% | -138,767![]() (-13.06%) | Filing History |
2022-02-14 5:06 pm Purchase | 2021-12-31 | 13G | RxSight, Inc. RXST | RxSight I LLC | 2,016,778 7.600% | 2,016,778![]() (New Position) | Filing History |
2022-02-14 3:53 pm Purchase | 2021-12-31 | 13G | RxSight, Inc. RXST | TAMER ANTHONY | 2,010,037 7.340% | 2,010,037![]() (New Position) | Filing History |
2022-02-14 2:40 pm Purchase | 2021-07-29 | 13G | RxSight, Inc. RXST | Wolfen Richard M. | 1,827,349 6.700% | 1,827,349![]() (New Position) | Filing History |
2022-02-11 4:42 pm Purchase | 2021-12-31 | 13G | RxSight, Inc. RXST | ORBIMED ADVISORS LLC | 1,062,500 3.900% | 1,062,500![]() (New Position) | Filing History |
2021-08-13 5:15 pm Purchase | 2021-08-03 | 13D | RxSight, Inc. RXST | Longitude Capital Partners II LLC | 2,506,972 9.100% | 2,506,972![]() (New Position) | Filing History |